ClinicalTrials.Veeva

Menu

[BrainConnexion] - Neurodevice Phase I Trial

N

National Neuroscience Institute

Status

Active, not recruiting

Conditions

Motor Neuron Disease
Tetraplegia
Locked-in Syndrome
Spinal Cord Injuries
Amyotrophic Lateral Sclerosis
Muscular Dystrophies
Tetraplegia/Tetraparesis

Treatments

Device: BrainConnexion

Study type

Interventional

Funder types

Other

Identifiers

NCT03811301
BrainConnexion

Details and patient eligibility

About

This study aims to evaluate the safety of a wireless implantable neurodevice microsystem in tetraplegic patients, as well as the efficacy of the electrodes for long-term recording of neural activities and the successful control of an external device.

Full description

The goal of this study is to develop a miniaturized wireless implantable neurodevice microsystem that records and transmits signals from the motor cortex of tetraplegic patients, bypassing the damaged nervous tissue, to control an external assistive device that restores some form of independence to patients in terms of communication or mobility.

Enrollment

5 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 21 years old and older
  2. Tetraparesis
  3. Written informed consent obtained from the patient or legal representative (in the event where the patient is unable to provide consent) prior to entry into the study in accordance with local EC/IRB regulations and/or other application regulations for surrogate consent.
  4. Able to perform the pre-operation Brain Computer Interface training as judged by the research team.

Exclusion criteria

  1. Significant medical co-morbidities e.g. cardiac disease
  2. Bleeding disorders
  3. Any contraindication to surgery
  4. Other concomitant intracranial pathologies
  5. History of seizures or epilepsy disorder
  6. Complications of coagulopathy
  7. Surgically unfit
  8. Significant psychological issues e.g. Depression
  9. Poor psychological support
  10. Pregnancy
  11. No means of communication
  12. Any disease, in the opinion of the Investigator, that is unstable or which could jeopardise the safety of the patient

If applicable, psychological assessment may be performed prior to selection as the implantation process will be a long a stressful event, requiring a significant degree of patient cooperation and resilience.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

5 participants in 1 patient group

Interventional
Experimental group
Description:
Wireless Implantable Neurodevice Microsystem
Treatment:
Device: BrainConnexion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems